Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
This clinical trial is evaluating whether transcranial direct current stimulation (tDCS) can alter synaptic density in the brains of people …
-
EMA withdrawal · 2025-09-23EMA Withdrawn: Olanzapine Apotex (olanzapine) — Apotex Europe BV
The EMA has withdrawn Olanzapine Apotex, an olanzapine product from Apotex Europe BV.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: State Representation in Early Psychosis
This ClinicalTrials.gov entry describes a University of Minnesota trial on state representation in early psychosis that has completed.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Bromocriptine for Patients With Schizophrenia and Prediabetes [Phase 4]
A Phase 4 clinical trial is evaluating bromocriptine for patients with schizophrenia and prediabetes, sponsored by the VA Pittsburgh Healthc…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions [Phase 1]
Phase 1 pharmacokinetic study evaluating VHX-896 in combination with iloperidone tablets under steady-state conditions; the study has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A Randomized Controlled Trial [NA]
This randomized controlled trial compared the effects of aerobic exercise and computerized cognitive stimulation in patients with schizophre…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Multidisciplinary Rehabilitation Program for Treatment-Resistant Psychotic Forensic Patients: A Comparative Study [NA]
A completed comparative clinical trial evaluating a multidisciplinary rehabilitation program for treatment-resistant schizophrenia in forens…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: The Effectiveness of Lower Extremity Strength Training [NA]
This completed clinical trial evaluated the effectiveness of lower extremity strength training in patients with chronic schizophrenia. The s…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia [NA]
Clinical trial update on using repetitive transcranial magnetic stimulation (rTMS) as an add-on therapy for negative symptoms in schizophren…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) [Phase 3]
Phase 3 trial evaluating dexmedetomidine for agitation associated with schizophrenia and bipolar disorder has completed.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations [NA]
A clinical trial evaluating real-time fMRI neurofeedback in patients with schizophrenia and auditory hallucinations is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Horyzons: Implementation and Integration in Clinical Practice [NA]
The Horyzons implementation study was terminated and results were posted on 2025-09-18. The trial focused on schizophrenia-spectrum disorder…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia [Phase 2]
This Phase 2 trial evaluated 10 mg and 30 mg doses of CVL-231 (emraclidine) in participants with schizophrenia; the study is completed and r…
-
FDA approval · 2025-09-17FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ziprasidone from Dr. Reddy's Laboratories Limited, indicating regulatory action on an existi…
-
FDA approval · 2025-09-17FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Ziprasidone hydrochloride submitted by Apotex Corp., for an already approved generic product. Th…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) [Phase 3]
This is an open-label Phase 3 long-term study assessing safety, tolerability, and efficacy of KarXT in adult patients with schizophrenia; th…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Sex Differences in NMDA-enhancing Treatment of Schizophrenia [Phase 2]
A Phase 2 clinical trial update on sex differences in an NMDA-enhancing treatment for schizophrenia, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: The Police-Mental Health Linkage System [NA]
Completed clinical trial update on the Police-Mental Health Linkage System sponsored by Columbia University, studying severe mental disorder…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia [Phase 1]
Phase 1 trial evaluating injectable naltrexone in combination with oral bupropion for smoking cessation in adults with schizophrenia has bee…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia [NA]
This clinical trial update notes a completed study evaluating repetitive transcranial magnetic stimulation (rTMS) for treating first rank sy…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Comparison of the Effects of Physical Activity and Virtual Reality Training in Patients With Schizophrenia [NA]
Completed clinical trial comparing physical activity versus virtual reality training in patients with schizophrenia to evaluate effects on b…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients [NA]
This clinical trial update notes an ongoing study at Istanbul Arel University evaluating an empowerment program for relatives of schizophren…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach [Phase 2]
A Phase 2 clinical trial comparing antipsychotic dose reduction versus maintenance treatment in people with schizophrenia spectrum disorders…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of an olanzapine titration schedule in patients with schizophrenia; the study…
-
FDA approval · 2025-09-12FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
The FDA approved a supplemental application for HALOPERIDOL DECANOATE submitted by Meitheal Pharmaceuticals Inc., expanding the regulatory a…